Applied DNA Sciences Reports Second Consecutive Quarter of Continued Revenue Growth.STONY BROOK Stony Brook may refer to: Massachusetts:
DNA or deoxyribonucleic acid One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes. Sciences, Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. : APDN) reported its revenues for the first fiscal quarter of 2008 ending December 2007. Revenues increased from $0 in the first quarter of 2007 to $123,167 in the first quarter of 2008. This is the second consecutive quarter of continued revenue growth for the company, which reported revenues of $121,920 in the fourth quarter of 2007. James A. Hayward, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of APDN said, "We are off to a positive start in fiscal 2008 and our first quarter results are in line with our expectations. We continue to be excited by the opportunities that await us this year and we believe we are uniquely positioned to grow, generating revenues from our SigNature[TM] DNA markers, DermalRx[TM] products and Fibertyping[TM]. As a company we are committed to further strengthening our position by expanding our customer base and developing a pipeline of solutions that effectively meet their needs." Following are recent highlights and developments: * February 2008 - SigNature[TM] DNA Marker Kits supplied to global cash-in-transit customer * January 2008 - Patents filed for optical DNA SigNature[TM] Markers, marking our entrance into the instant detection market * First quarter of 2008 - Development and testing of a unique assay to differentiate between Pima and Upland Cotton upland cotton n. A tropical American plant (Gossypium hirsutum) widely cultivated for the woolly lint that surrounds its seeds. Noun 1. (Fibertyping)[TM] for Supima * November 2007- First commercial order of DermalRx[TM] "We are very pleased with our first quarter results," stated Kurt Jensen, ADNAS Chief Financial Officer. "This is a dynamic time for our company and we remain very focused on driving growth, managing the day-to-day business and serving the diverse needs of our expanding customer base throughout the world." About APDN Applied DNA Sciences markets and sells DNA encrypted and embedded solutions that are forensically authenticated au·then·ti·cate tr.v. au·then·ti·cat·ed, au·then·ti·cat·ing, au·then·ti·cates To establish the authenticity of; prove genuine: a specialist who authenticated the antique samovar. by machine readable Data in a form that can be read by the computer, which includes disks, tapes and punch cards. Printed fonts that can be scanned and recognized by the computer are also machine readable. devices. These solutions can be easily integrated with a range of inks, threads, varnishes, adhesives as well as thermal ribbon, inkjet and laser ink. Applied DNA Sciences' products can help protect the brands and intellectual property that can easily be eroded by counterfeiting, product diversion and fraud. The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-KSB, filed on January 15, 2008 and our subsequent quarterly reports on Form 10-QSB. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion